Novo Nordisk is cutting the out-of-pocket prices of its popular weight-loss drug Wegovy and diabetes drug Ozempic for some consumers. Current customers who pay for the drugs out of pocket — without the help of health insurance — will now be charged $349 per month, down from $499, the Danish drugmaker said Monday. Novo Nordisk also announced that it will charge $199 per month for new patients who pay for the drugs out of pocket, with the offer covering two months of the treatments. After that,